Browse content similar to Francoise Barre-Sinoussi - President Elect, International AIDS Society. Check below for episodes and series from the same categories and more!
Line | From | To | |
---|---|---|---|
risen to 61 people. Time for HARDtalk. Could we soon | :00:09. | :00:18. | |
see a cure for her HIV/AIDS? Francoise Barre-Sinoussi thinks so. | :00:18. | :00:21. | |
She is a Nobel Prize winner who helped to identify the virus 30 | :00:21. | :00:25. | |
years ago. She says the need to pour money into fighting the | :00:25. | :00:30. | |
disease is as great as ever. Already, nearly 30 million have | :00:30. | :00:34. | |
died from it. By the time I have finished this introduction another | :00:34. | :00:37. | |
three people will have contracted it. Another two will have died. But | :00:37. | :00:47. | |
:00:47. | :01:09. | ||
with budgets being cut, can we afford more expensive research? | :01:09. | :01:11. | |
Francoise Barre-Sinoussi, welcome to HARDtalk. | :01:11. | :01:16. | |
Thank you. It seems extraordinary that a short | :01:16. | :01:20. | |
time ago scientists were barely talking about a cure for AIDS, and | :01:20. | :01:23. | |
now you are saying that it is a potential reality for the near | :01:23. | :01:27. | |
future. How did the change come about? | :01:27. | :01:35. | |
First of all, it is not new to talk about a cure. But with any great | :01:35. | :01:38. | |
certainty it is. Of course it has been researched | :01:38. | :01:41. | |
already. A bunch of scientists were working already on that aspect | :01:41. | :01:48. | |
without any results. The reason why we're talking about a cure today is | :01:48. | :01:57. | |
because we have some evidence that it might be possible. First of all | :01:57. | :02:01. | |
we have what we call the Berlin patient, the patient that is HIV | :02:01. | :02:04. | |
positive, had a bone transplant because he developed leukaemia, and | :02:04. | :02:08. | |
it turned out that after two bone marrow transplants, we can say that | :02:08. | :02:18. | |
:02:18. | :02:22. | ||
we cannot detect the virus in his body anymore. It is the proof of a | :02:22. | :02:25. | |
concept somehow that we did not have before. There is also this | :02:25. | :02:28. | |
group of individuals that are HIV positive for many years, some of | :02:28. | :02:38. | |
:02:38. | :02:44. | ||
them 15 years. It is a small group, less than 1%. They have never | :02:44. | :02:47. | |
received any treatment and they are doing well. They control their | :02:47. | :02:50. | |
virus. I want to talk to you more about | :02:51. | :02:55. | |
the science behind it, how it might work, in a moment. But first of all, | :02:55. | :02:58. | |
you have described the search for a cure as a necessity. Because of | :02:58. | :03:05. | |
your concerns about the long-term efficacy of treatment. Why are you | :03:05. | :03:08. | |
saying that now more than ever before it is necessary to find a | :03:08. | :03:17. | |
cure? Why is it so necessary? First of all I will not say that it | :03:17. | :03:20. | |
is because of a lack of long-term efficacy of the treatment, because | :03:20. | :03:24. | |
the treatment we have today it is a good treatment. We know that we can | :03:24. | :03:34. | |
reduce the mortality by 90%. It is not a bad treatment at all. The | :03:34. | :03:38. | |
reason why we are pushing for a cure is because we know that it is | :03:38. | :03:43. | |
a lifelong treatment. We know that it is of course very difficult for | :03:43. | :03:51. | |
access, universal access to treatment, for everybody. We know | :03:51. | :03:54. | |
as well that there is a small proportion of patients that on | :03:54. | :04:01. | |
long-term treatment are developing complications. That means that we | :04:01. | :04:08. | |
need to have new tools for the future. We have wonderful treatment | :04:08. | :04:14. | |
that is efficient today. Presumably there is also a danger | :04:14. | :04:17. | |
with the treatment, because it is something that people have to take | :04:17. | :04:21. | |
every single day for the rest of their lives. If they cannot do that | :04:21. | :04:25. | |
you could end up with a resistant strain of the virus. | :04:25. | :04:30. | |
That is right. We know that adherence to the treatment is very | :04:30. | :04:32. | |
important otherwise they can develop resistance to treatment, | :04:32. | :04:35. | |
and they can also transmit a resistant form of the virus to | :04:35. | :04:45. | |
:04:45. | :04:48. | ||
others. Of course this is a problem. But mostly, the current treatment | :04:48. | :04:53. | |
is very efficient. Is there a danger if you find a | :04:53. | :04:56. | |
cure, though, that it will mean people will be less concerned about | :04:56. | :04:59. | |
preventing getting the disease in the first place? | :04:59. | :05:06. | |
If we have new tools for a cure... Maybe we should define 'cure' first. | :05:06. | :05:13. | |
'Cure' means that you totally eliminate the virus from the body. | :05:13. | :05:18. | |
But there is another definition of cure. It is what we call functional | :05:18. | :05:24. | |
cure. That means that you control persistently the infection without | :05:24. | :05:32. | |
total elimination of the virus on the body. | :05:32. | :05:37. | |
Forgive me for interrupting. The effects could mean that people will | :05:37. | :05:46. | |
revert to the sort of behaviour that help spread the disease. Using | :05:46. | :05:56. | |
:05:56. | :05:59. | ||
condoms for example. That was difficult to get people to use them. | :05:59. | :06:02. | |
If people can control by themselves their infec their infecey | :06:02. | :06:05. | |
will not transmit to others. We know that already. We know that | :06:05. | :06:11. | |
with the actual treatment. We know that treatment is also prevention. | :06:11. | :06:14. | |
We know that if we are efficiently controlling the virus in the body, | :06:15. | :06:22. | |
then the virus is not transmitted to others. Imagine the future. | :06:22. | :06:26. | |
Imagine that we have a treatment that the patient can stop, but they | :06:26. | :06:30. | |
keep their virus under control. They will not transmit to others | :06:31. | :06:35. | |
anymore. Understood, but do you not fear | :06:35. | :06:38. | |
that people will become less responsible about the way in which | :06:38. | :06:41. | |
they have sexual relations, the way in which they use intravenous | :06:41. | :06:47. | |
drugs? I mean, of course there is always | :06:47. | :06:55. | |
education, counselling, and that will be a continuing effort. It is | :06:55. | :06:58. | |
part of the prevention. It is part of education. That should remain | :06:59. | :07:05. | |
forever. Let me ask you to explain a little | :07:05. | :07:09. | |
bit, take me through gently if you will, but a little bit about the | :07:09. | :07:13. | |
science of how this cure might work. From what I understand it involves | :07:13. | :07:16. | |
interfering with some protein in the cell which is an entry point | :07:16. | :07:23. | |
for the virus. Is that correct? It is one target. It is not the | :07:23. | :07:27. | |
only one. Of course, the fact that the current treatment we have | :07:27. | :07:30. | |
cannot be stopped and is lifelong is because the virus remains | :07:30. | :07:40. | |
:07:40. | :07:45. | ||
dormant in some cells of the immune system. What you are mentioning is | :07:45. | :07:48. | |
one of the approaches, to reactivate the dormant virus from | :07:48. | :07:56. | |
these cells. We have already some data indicating that probably will | :07:56. | :08:06. | |
:08:06. | :08:07. | ||
not be sufficient. You also have to probably stimulate the immune | :08:07. | :08:12. | |
that reactivates the virus from the dormant cells with a kind of | :08:12. | :08:22. | |
:08:22. | :08:25. | ||
vaccination. And you need to eliminate immediately the | :08:25. | :08:35. | |
:08:35. | :08:37. | ||
reactivated cells. Isn't this a form of gene therapy? | :08:37. | :08:42. | |
If it is, I realise I am probably using a shorthand, but if it is, I | :08:42. | :08:52. | |
:08:52. | :08:56. | ||
am just wondering how far can that be scaled up? Gene therapy is | :08:56. | :09:00. | |
labour intensive. It is expensive. It is difficult to see it being | :09:00. | :09:03. | |
rolled out across the world. Gene therapy is one approach, but | :09:03. | :09:08. | |
not the only one. For example, there is also the approaches that | :09:08. | :09:11. | |
are already ongoing, like using drugs targeting some of the enzymes | :09:11. | :09:16. | |
that explain why the virus remains dormant. That is not gene therapy | :09:16. | :09:24. | |
at all. It is just using a drug. Do you fear that in this search, in | :09:24. | :09:28. | |
the push to find a cure, that you could end up diverting money away | :09:28. | :09:38. | |
:09:38. | :09:41. | ||
from more established ways of tackling the disease? | :09:41. | :09:43. | |
Certainly that is not the goal at all. | :09:43. | :09:48. | |
I realise that. But is that not a concern given that money is tight? | :09:48. | :09:51. | |
People know that there is a certain amount of money for AIDS research. | :09:51. | :10:00. | |
It could leave other people exposed. The idea is to try to have | :10:00. | :10:05. | |
investment of both. We as a group of researchers are trying to | :10:05. | :10:13. | |
accelerate research on HIV cure. Investment for current access to | :10:13. | :10:19. | |
care, of prevention and treatment should continue. Research for a | :10:19. | :10:29. | |
vaccine should continue. Indeed, a vaccine might be part of the cure. | :10:29. | :10:37. | |
So we need to continue to invest in both. The treatment that we have | :10:37. | :10:40. | |
today is short, middle term approach to try to control the | :10:40. | :10:50. | |
:10:50. | :10:55. | ||
infection. We are thinking about the future. | :10:55. | :10:59. | |
What do you say to those people who say, as it is, AIDS research gets | :10:59. | :11:03. | |
basically too much money? There is too much money for this disease | :11:03. | :11:11. | |
when there are other diseases out there not being dealt with. | :11:11. | :11:21. | |
:11:21. | :11:31. | ||
HIV is a virus that attacks the cells of the immune system. It is | :11:31. | :11:34. | |
also a tool to understand better the immune system and how the | :11:34. | :11:40. | |
immune system functions. Why in that case would somebody | :11:40. | :11:43. | |
like an AIDS expert, somebody like Dr Malcolm Potts from the | :11:44. | :11:47. | |
University of California, say that if we look at data objectively we | :11:47. | :11:55. | |
are spending too much on AIDS? I know this kind of statement from | :11:55. | :11:59. | |
several scientists in the world that are not generally involved in | :11:59. | :12:02. | |
HIV research. Well, he is. | :12:02. | :12:06. | |
I think myself that you have to consider what is the progress that | :12:06. | :12:16. | |
:12:16. | :12:23. | ||
has been made that may be useful for other diseases. | :12:23. | :12:26. | |
But it is not just about high-end science that you are talking about. | :12:26. | :12:32. | |
It is about aid budgets generally. If we think about one-fifth of all | :12:32. | :12:34. | |
global deaths from diarrhoea occur in just three African countries, | :12:34. | :12:44. | |
:12:44. | :12:45. | ||
but they have relatively low HIV prevalence. | :12:45. | :12:48. | |
Yet they get very scant attention from those preventable deaths, but | :12:48. | :12:52. | |
a huge amount of money for their AIDS-related programmes. You can | :12:52. | :12:55. | |
understand why some people say that the AIDS programme completely | :12:55. | :13:05. | |
:13:05. | :13:06. | ||
distorts medical budgets. It is a question of budget for | :13:06. | :13:13. | |
global health. That is not related to science. If you look at the | :13:14. | :13:17. | |
effort that has been made in several countries for HIV/AIDS, we | :13:17. | :13:20. | |
are starting to see the impact on the global health in those | :13:20. | :13:28. | |
countries, not only in the HIV/AIDS field. I agree there is not enough | :13:28. | :13:34. | |
data. I used to say to people, we must have more data and evidence | :13:34. | :13:37. | |
showing that investment that has been made for different diseases | :13:37. | :13:47. | |
:13:47. | :13:52. | ||
and the impact on other diseases. My point is that there is finite | :13:52. | :14:02. | |
:14:02. | :14:07. | ||
amount of money and even more money is set to go. It could end up that | :14:07. | :14:11. | |
money is going into AIDS research and away from other programmes | :14:11. | :14:17. | |
which could possibly prevent more deaths. | :14:17. | :14:21. | |
I do not believe so myself because when we look at the research, one | :14:21. | :14:24. | |
characteristic of HIV is that the virus can induce chronic | :14:24. | :14:33. | |
inflammation. And we are trying to understand chronic inflammation, | :14:33. | :14:35. | |
which is one characteristic of cancer and cardiovascular disease | :14:35. | :14:44. | |
and ageing disease. If we understand better the mechanism of | :14:44. | :14:54. | |
:14:54. | :14:57. | ||
chronic inflammation, we can help other diseases as well. Instead of | :14:57. | :15:01. | |
opposing HIV research or funding I think it will be more intelligent | :15:01. | :15:11. | |
:15:11. | :15:18. | ||
to work together. Especially at a time of economic crisis. | :15:18. | :15:23. | |
We have talked about money. Let's also talk about how people see the | :15:23. | :15:32. | |
disease. You became very upset when the Pope, on his visit to Africa in | :15:32. | :15:35. | |
2009, said that AIDS was a tragedy that could not be overcome by money | :15:35. | :15:38. | |
or the distribution of condoms, which even aggravated the problem. | :15:38. | :15:42. | |
You wrote an open letter to the Pope and he seemed to change his | :15:42. | :15:46. | |
stance slightly after that. To allow for the use of condoms in | :15:46. | :15:56. | |
:15:56. | :16:01. | ||
How do you respond to the apparent shifting? Some changes in his | :16:01. | :16:09. | |
position. Was it an improvement? Certainly not because he mentioned | :16:09. | :16:18. | |
specific circumstances. The original statement was indicating | :16:18. | :16:28. | |
:16:28. | :16:43. | ||
that condoms were not fully demonstrated as efficient. | :16:43. | :16:47. | |
principle point was that the problem about the prevalence of | :16:47. | :16:57. | |
condoms is that it makes, in his words, sexuality banal. If you look | :16:57. | :17:06. | |
at the reality. Myself, I have met nuns and priests working in Africa | :17:06. | :17:16. | |
:17:16. | :17:19. | ||
and Asia. They are facing the reality. They are distributing | :17:19. | :17:24. | |
condoms themselves. The evidence is that you are struggling to win the | :17:24. | :17:31. | |
argument. If we look at a couple of states in the US Utah and Wisconsin | :17:31. | :17:34. | |
- they are considering bringing in a new law which will teach | :17:34. | :17:41. | |
abstinence as the contraceptive to children. Why are you losing the | :17:41. | :17:51. | |
:17:51. | :17:55. | ||
argument in places like that? counselling that is done before and | :17:55. | :18:05. | |
:18:05. | :18:05. | ||
after testing for HIV. All the means you mention - abstinence, or | :18:05. | :18:15. | |
:18:15. | :18:20. | ||
at least education, are part of the counselling given. If people do not | :18:20. | :18:25. | |
have sex they will not contract HIV. But, given that you think it is not | :18:25. | :18:28. | |
the most efficient or the only route, why are you losing the | :18:28. | :18:38. | |
:18:38. | :18:41. | ||
argument in places like Utah and Wisconsin? I am not losing the | :18:41. | :18:44. | |
argument. I say that prevention is a combination of different | :18:44. | :18:54. | |
:18:54. | :18:57. | ||
approaches. Changing behaviour is part of prevention. Condoms and | :18:57. | :19:07. | |
circumcision and treatment are all parts of prevention. Already we | :19:07. | :19:16. | |
know that the combination of tools for prevention are needed. I am not | :19:17. | :19:22. | |
pushing only the condom. Let me take you into an area where you are | :19:22. | :19:27. | |
pushing something quite dramatic - intravenous drug use. You have | :19:27. | :19:35. | |
called for a complete decriminalisation of drug use. | :19:35. | :19:45. | |
:19:45. | :19:54. | ||
That flies in the face of most legislation in the world. There are | :19:54. | :19:58. | |
few politicians who would endorse such a move. I am a scientist so I | :19:58. | :20:05. | |
always take that into consideration. The French government is opposed to | :20:05. | :20:15. | |
:20:15. | :20:16. | ||
the creation of supervised injection centres for drug addicts. | :20:16. | :20:23. | |
Why do you think it would help to have it decriminalised? Research | :20:23. | :20:25. | |
shows that repressive measures do not improve access to care, | :20:26. | :20:35. | |
:20:36. | :20:47. | ||
prevention and treatment for IV drug users. Repressive measures are | :20:47. | :20:57. | |
:20:57. | :20:57. | ||
negative. As a scientist I base my opinion on that. Even if it flies | :20:57. | :21:00. | |
in the face of political orthodoxy, you are willing to go there? It is | :21:00. | :21:03. | |
interesting to hear you talk in this way because you do not just | :21:04. | :21:10. | |
see yourself as a scientist, but also an activist. You use terms | :21:10. | :21:18. | |
which are not scientific, not cool and calculating. You talk about | :21:18. | :21:25. | |
your upset, your fury about your fight for funding, for example. Why | :21:25. | :21:29. | |
in these terms? Because, as a scientist, like many others, I have | :21:29. | :21:32. | |
worked to contribute to the development of truth for the | :21:32. | :21:42. | |
:21:42. | :21:46. | ||
benefit of humanity. Globally. And why I say sometimes that I am | :21:46. | :21:56. | |
:21:56. | :22:00. | ||
furious is because we have to live together today. And when I see that | :22:00. | :22:07. | |
the tools are not available for everyone, that makes me furious. | :22:07. | :22:17. | |
:22:17. | :22:24. | ||
Because they are diverted to the banking crisis? To what? Because of | :22:24. | :22:27. | |
discrimination and stigmatisation of some of the population. That is | :22:27. | :22:37. | |
:22:37. | :22:38. | ||
opposing access to testing and counselling and care and treatment. | :22:38. | :22:41. | |
Because of the restricted funding that limits the access to treatment | :22:41. | :22:51. | |
:22:51. | :22:54. | ||
for everyone. We have seen during the last year that there is all the | :22:54. | :22:57. | |
international affect we have been able to go from 50,000 people on | :22:57. | :23:07. | |
treatment to 7 million people on treatment. How concerned are you | :23:07. | :23:11. | |
that even if the fight against Aids is won that the next pandemic is | :23:11. | :23:15. | |
just around the corner? Especially with the increasing | :23:15. | :23:23. | |
interconnectedness of the world? That can happen but I think we | :23:23. | :23:30. | |
should keep in mind the experience of HIV/Aids. Think of it as a kind | :23:30. | :23:40. | |
:23:40. | :23:44. | ||
of model. In the early 80s we used to say it was a crisis. An | :23:44. | :23:50. | |
emergency. People were dying. has been an emergency for 30 years, | :23:50. | :23:53. | |
and one which you have been involved in. When will we see a | :23:53. | :24:03. | |
:24:03. | :24:06. | ||
cure? I cannot answer this question if I am honest. We do not know. | :24:06. | :24:10. |